Dupic Cent subcutaneous injection 300 mg syringe

Dupic Cent subcutaneous injection 300 mg syringe, containing dupilumab (genetical recombination) and manufactured by Sanofi, is an injectable biologic medication. Dupilumab is approved to treat various inflammatory conditions such as moderate-to-severe atopic dermatitis (eczema), asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, and chronic spontaneous urticaria. This 300mg 2mL 1 tube formulation has a YJ code of 4490405G1024.